comparemela.com

Latest Breaking News On - Investments in research - Page 7 : comparemela.com

Oncodesign Confirms Its Very Good Results in 2021 and an Attractive Outlook For 2022

Group turnover up by 23% at €31.3 millionOperating income and revenue of €36.2M, offsetting the foreseen discontinuation of the GSK subsidy (€8M)R&D investments amounting to €7.4MNet profit/loss near the break-even point (-€0.3M)Service BU:Very strong organic growth in external turnover at +31%, reaching €27.6M,EBIT.

Oncodesign ONCODESIGN: Oncodesign Confirms Its Very Good Results in 2021 and an Attractive Outlook For 2022

Group turnover up by 23% at €31.3 million Operating income and revenue of €36.2M, offsetting the foreseen discontinuation of the GSK subsidy (€8M) R&D investments amounting to €7.4M

The Worldwide Potato Starch Industry is Expected to Reach $5 2 Billion by 2027

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.